
Oria
Organelles (nucleus, lysosome, mitochondria, etc.) are compartments located inside the cell, hardly accessible. Only 10% of drugs act on organelle proteins, even though they are five times more numerous than external membrane targets. Currently, it is impossible for laboratories to screen drug candidates targeting organelle targets, at high-throughput. Organelles are difficult to access, and Drug Discovery efficacy tests are unreliable. At Oria, we are developing the first high-throughput organelle purification method in microfluidics, keeping their native target activity and compatible with High Throughput Screening methods. This technology, intended for pharmaceutical laboratories and drug discovery CROs will allow them to perform lysosomal screening 100 times faster on First-In-Class Targets for neurodegenerative diseases, cancers and cardiovascular diseases.
Process Overview: Oria Bioscience develops a high-throughput organelle purification method using microfluidics. This method maintains the native target activity of the organelles and is compatible with High Throughput Screening (HTS) methods. The process involves purifying organelles such as lysosomes, which are then used for drug discovery and screening.
Experience and Expertise: More than a decade of experience
Customer Rating:
Licenses and Certifications: Not available
Types of Services: Biotech, Health tech biotech, Nanotech, Health tech digital
Specialised services
- 10x10 Bathroom Remodel
- Master Bathroom Remodel
- One Day Bath Fitter Installation
- Small Bathroom Renovation
Services and price range
- 10x10 Bathroom Remodel Cost
- Master Bathroom Remodel Cost Breakdown
- One Day Bath Fitter Cost
- Small Bathroom Renovation Cost
Timeline and Project Management: Timely delivery is implied as they plan to commercialize their first product by March 2025 after a fundraise starting in September 2024.
Testimonials:
Not available
Contact Information:
Website :https://www.euroquity.com/en/company/oria-bioscience Email : Not available Call – Not available



